Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

The age-old advice to lose weight is to exercise and eat healthy, but what if you can’t work out regularly (or just don’t ...